ResearcherSanofiNo recent work listed
Clinical Sciences & Operations
Known by name at one institution; no external author ID yet. Name as it appears in ClinicalTrials.gov.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 0
- Pancreatic cancer trials
- 8
- Pancreatic cancer grants
- 0
- Collaborators
- 0
2006: 1 trial · 2007: 1 trial · 2008: 1 trial · 2009: none · 2010: 1 trial · 2011: none · 2012: none · 2013: none · 2014: 1 trial · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 trial · 2020: none · 2021: 2 trials
Trials 8
- Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors Study director NCT04659603↗
- Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors Study director NCT04717375↗
- A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab… Study director NCT03829501↗
- Evaluation of SAR408701 in Patients With Advanced Solid Tumors Study director NCT02187848↗
- Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer Study director NCT01121848↗
- S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regimen Study director NCT00602745↗
- Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer Study director NCT00574275↗
- Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma Study director NCT00681798↗
Closest collaborators
No collaborators recorded.
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.